Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging

M. Sato, M. L. Figueiredo, J. B. Burton, M. Johnson, M. Chen, R. Powell, S. S. Gambhir, M. Carey, L. Wu

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Effective treatment for recurrent, disseminated prostate cancer is notably limited. We have developed adenoviral vectors with a prostate-specific two-step transcriptional amplification (TSTA) system that would express therapeutic genes at a robust level to target metastatic disease. The TSTA system employs the prostate-specific antigen (PSA) promoter/enhancer to drive a potent synthetic activator, which in turn activates the expression of the therapeutic gene. In this study, we explored different configurations of this bipartite system and discovered that physical separation of the two TSTA components into E1 and E3 regions of adenovirus was able to enhance androgen regulation and cell-discriminatory expression. The TSTA vectors that express imaging reporter genes were assessed by noninvasive imaging technologies in animal models. The improved selectivity of the E1E3 configured vector was reflected in silenced ectopic expression in the lung. Significantly, the enhanced specificity of the E1E3 vector enabled the detection of lung metastasis of prostate cancer. An E1E3 TSTA vector that expresses the herpes simplex virus thymidine kinase gene can effectively direct positron emission tomography (PET) imaging of the tumor. The prostate-targeted gene delivery vectors with robust and cell-specific expression capability will advance the development of safe and effective imaging guided therapy for recurrent metastatic stages of prostate cancer.

Original languageEnglish (US)
Pages (from-to)583-593
Number of pages11
JournalGene Therapy
Volume15
Issue number8
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Gene Expression
Prostate
Genes
Lung
Thymidine Kinase
Simplexvirus
Prostate-Specific Antigen
Reporter Genes
Adenoviridae
Positron-Emission Tomography
Androgens
Therapeutics
Animal Models
Neoplasm Metastasis
Technology
Neoplasms
Ectopic Gene Expression

ASJC Scopus subject areas

  • Genetics

Cite this

Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging. / Sato, M.; Figueiredo, M. L.; Burton, J. B.; Johnson, M.; Chen, M.; Powell, R.; Gambhir, S. S.; Carey, M.; Wu, L.

In: Gene Therapy, Vol. 15, No. 8, 2008, p. 583-593.

Research output: Contribution to journalArticle

Sato, M, Figueiredo, ML, Burton, JB, Johnson, M, Chen, M, Powell, R, Gambhir, SS, Carey, M & Wu, L 2008, 'Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging', Gene Therapy, vol. 15, no. 8, pp. 583-593. https://doi.org/10.1038/gt.2008.19
Sato, M. ; Figueiredo, M. L. ; Burton, J. B. ; Johnson, M. ; Chen, M. ; Powell, R. ; Gambhir, S. S. ; Carey, M. ; Wu, L. / Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging. In: Gene Therapy. 2008 ; Vol. 15, No. 8. pp. 583-593.
@article{2966924867d044d0b20adc44c9c98f3e,
title = "Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging",
abstract = "Effective treatment for recurrent, disseminated prostate cancer is notably limited. We have developed adenoviral vectors with a prostate-specific two-step transcriptional amplification (TSTA) system that would express therapeutic genes at a robust level to target metastatic disease. The TSTA system employs the prostate-specific antigen (PSA) promoter/enhancer to drive a potent synthetic activator, which in turn activates the expression of the therapeutic gene. In this study, we explored different configurations of this bipartite system and discovered that physical separation of the two TSTA components into E1 and E3 regions of adenovirus was able to enhance androgen regulation and cell-discriminatory expression. The TSTA vectors that express imaging reporter genes were assessed by noninvasive imaging technologies in animal models. The improved selectivity of the E1E3 configured vector was reflected in silenced ectopic expression in the lung. Significantly, the enhanced specificity of the E1E3 vector enabled the detection of lung metastasis of prostate cancer. An E1E3 TSTA vector that expresses the herpes simplex virus thymidine kinase gene can effectively direct positron emission tomography (PET) imaging of the tumor. The prostate-targeted gene delivery vectors with robust and cell-specific expression capability will advance the development of safe and effective imaging guided therapy for recurrent metastatic stages of prostate cancer.",
author = "M. Sato and Figueiredo, {M. L.} and Burton, {J. B.} and M. Johnson and M. Chen and R. Powell and Gambhir, {S. S.} and M. Carey and L. Wu",
year = "2008",
doi = "10.1038/gt.2008.19",
language = "English (US)",
volume = "15",
pages = "583--593",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging

AU - Sato, M.

AU - Figueiredo, M. L.

AU - Burton, J. B.

AU - Johnson, M.

AU - Chen, M.

AU - Powell, R.

AU - Gambhir, S. S.

AU - Carey, M.

AU - Wu, L.

PY - 2008

Y1 - 2008

N2 - Effective treatment for recurrent, disseminated prostate cancer is notably limited. We have developed adenoviral vectors with a prostate-specific two-step transcriptional amplification (TSTA) system that would express therapeutic genes at a robust level to target metastatic disease. The TSTA system employs the prostate-specific antigen (PSA) promoter/enhancer to drive a potent synthetic activator, which in turn activates the expression of the therapeutic gene. In this study, we explored different configurations of this bipartite system and discovered that physical separation of the two TSTA components into E1 and E3 regions of adenovirus was able to enhance androgen regulation and cell-discriminatory expression. The TSTA vectors that express imaging reporter genes were assessed by noninvasive imaging technologies in animal models. The improved selectivity of the E1E3 configured vector was reflected in silenced ectopic expression in the lung. Significantly, the enhanced specificity of the E1E3 vector enabled the detection of lung metastasis of prostate cancer. An E1E3 TSTA vector that expresses the herpes simplex virus thymidine kinase gene can effectively direct positron emission tomography (PET) imaging of the tumor. The prostate-targeted gene delivery vectors with robust and cell-specific expression capability will advance the development of safe and effective imaging guided therapy for recurrent metastatic stages of prostate cancer.

AB - Effective treatment for recurrent, disseminated prostate cancer is notably limited. We have developed adenoviral vectors with a prostate-specific two-step transcriptional amplification (TSTA) system that would express therapeutic genes at a robust level to target metastatic disease. The TSTA system employs the prostate-specific antigen (PSA) promoter/enhancer to drive a potent synthetic activator, which in turn activates the expression of the therapeutic gene. In this study, we explored different configurations of this bipartite system and discovered that physical separation of the two TSTA components into E1 and E3 regions of adenovirus was able to enhance androgen regulation and cell-discriminatory expression. The TSTA vectors that express imaging reporter genes were assessed by noninvasive imaging technologies in animal models. The improved selectivity of the E1E3 configured vector was reflected in silenced ectopic expression in the lung. Significantly, the enhanced specificity of the E1E3 vector enabled the detection of lung metastasis of prostate cancer. An E1E3 TSTA vector that expresses the herpes simplex virus thymidine kinase gene can effectively direct positron emission tomography (PET) imaging of the tumor. The prostate-targeted gene delivery vectors with robust and cell-specific expression capability will advance the development of safe and effective imaging guided therapy for recurrent metastatic stages of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=43049165871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049165871&partnerID=8YFLogxK

U2 - 10.1038/gt.2008.19

DO - 10.1038/gt.2008.19

M3 - Article

C2 - 18305574

AN - SCOPUS:43049165871

VL - 15

SP - 583

EP - 593

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 8

ER -